We’re sorry, something doesn't seem to be working properly.
Please try refreshing the page. If that doesn't work, please contact us so we can address the problem.
Open access in 2011: a publisher's perspective
- Nandita A Quaderi1
© Quaderi; licensee BioMed Central Ltd. 2011
- Published: 3 October 2011
- Infectious Disease
- Cancer Research
- Open Access
- Recent Progress
- Lead Role
Over the last decade the open access (OA) publishing model has secured itself as an integral part of the biomedical publishing landscape. Furthermore, as a growing number of funding agencies introduce OA mandates, it is becoming increasingly important for researchers and institutions to comply with these policies. This presentation will summarise the different routes to achieving open access and give an overview of recent progress and developments in OA publishing.
One of the key benefits of OA is the removal of subscription barriers to published research - this is especially true for communities that suffer from limited visibility for their research output and/or access to the necessary scholarly journals. BioMed Central is taking a lead role in raising awareness of the advantages of OA, and making OA an affordable publishing option, for researchers based in Africa and other parts of the developing world. The second part of this presentation will focus on these initiatives.
This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.